Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
109,272,143
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
590,438
-
Shares change
-
+174,555
-
Total reported value, excl. options
-
$816,220
-
Value change
-
+$77,206
-
Number of buys
-
10
-
Number of sells
-
-11
-
Price
-
$1.39
Significant Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q1 2020
33 filings reported holding ONCY - ONCOLYTICS BIOTECH INC - Common Stock, no par value as of Q1 2020.
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 590,438 shares
of 109,272,143 outstanding shares and own 0.54% of the company stock.
Largest 10 shareholders include TWO SIGMA ADVISERS, LP (150,700 shares), Creative Planning (93,000 shares), ROYAL BANK OF CANADA (53,976 shares), SCOTIA CAPITAL INC. (47,227 shares), WEDBUSH SECURITIES INC (44,705 shares), RENAISSANCE TECHNOLOGIES LLC (41,999 shares), BANCO BILBAO VIZCAYA ARGENTARIA, S.A. (30,000 shares), CIBC World Markets Inc. (17,400 shares), COMERICA BANK (15,526 shares), and INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC (14,139 shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.